Regenxbio (NASDAQ:RGNX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.

Open	$8.80
Close	$8.59
Volume / Avg.	502.23K / 492.99K
Day Range	$8.57 - $8.98
52 Wk Range	8.82 - 28.80
Market Cap	$424.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	13.21%
Days to Cover	9.55

Recent News

Wall Street Analysts Think Regenxbio Could Surge 234.37%: Read This Before Placing a Bet

Shares of Regenxbio (NASDAQ: RGNX) have gained 17.7% over the past four weeks to close the last trading session at $12.51, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.

Zacks

Why Is Clearside Biomedical Stock Gaining Today?

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS Microinjector and strategic partnerships.

Vandana Singh

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy

The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older with specific DMD gene mutations.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.80
Close	$8.59
Volume / Avg.	502.23K / 492.99K
Day Range	$8.57 - $8.98
52 Wk Range	8.82 - 28.80
Market Cap	$424.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	13.21%
Days to Cover	9.55

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Altimmune (NASDAQ:ALT).

What is the forecast, or price target, for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $42.07.

What is the current price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $8.59 last updated October 31, 2024 at 6:08 PM EDT.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Regenxbio

Regenxbio (RGNX) Forecast